Transplantation for Renal Amyloidosis
作者:
KiliçturgaySadik,
HaberalMehmet,
期刊:
Renal Failure
(Taylor Available online 1993)
卷期:
Volume 15,
issue 5
页码: 629-633
ISSN:0886-022X
年代: 1993
DOI:10.3109/08860229309069414
出版商: Taylor&Francis
关键词: Amyloidosis;Familial Mediterranean fever (FMF);Renal failure;Renal transplantation
数据来源: Taylor
摘要:
Renal transplantation therapy performed for amyloid nephropathy is controversial because of the fatal effects of the disease. Amyloidosis is a relatively frequent disease and is generally associated with familial Mediterranean fever (FMF) in Turkey. Renal transplantation in the treatment of amyloid nephropathy started in January 1985. Till now, 18 (3.2%) renal transplantations have been performed on patients who had amyloid nephropathy. The mean followup period was 34.6 months. Fourteen renal grafts still function well (creatinine: 1–3.2 mgldL). The overall 1-year patient and graft survival rates were 88.9% and 83.0%, respectively. These rates are not statistically different from renal transplantations done for other cases of renal failure. Therefore, patients with end-stage renal failure due to amyloidosis can be considered as appropriate candidates for renal transplantation.
点击下载:
PDF (415KB)
返 回